Investor Relations

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Theravance, Inc. Investor Relations SEC Filings section.


SEC Filings
Date Filed Filing Description View
May 10, 2017 10-Q quarterly report HTML PDF XLS XBRL Add to Briefcase
May 9, 2017 8-K current report HTML PDF XLS Add to Briefcase
Apr 11, 2017 DEF 14A definitive proxy statement HTML PDF XLS Add to Briefcase
Mar 8, 2017 4 haumann, brett k HTML PDF XLS Add to Briefcase
Mar 7, 2017 4 shafer, bradford j HTML PDF XLS Add to Briefcase
Mar 3, 2017 S-8 registration statement HTML PDF XLS Add to Briefcase
Mar 1, 2017 10-K annual report HTML PDF XLS XBRL Add to Briefcase
Feb 27, 2017 8-K current report HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 winningham, rick e HTML PDF XLS Add to Briefcase
Feb 22, 2017 4 pitzer, kenneth r HTML PDF XLS Add to Briefcase
FirstPrevious
3
... NextLast
Add to Briefcase = add PDF file to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)